简介内容:Keliximab (SB-210396), a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody, demonstrates a binding affinity for soluble CD4 with a K i value of nM. It inhibits T cell proliferation and IL-2 production, making it a valuable agent for cancer research [1] [2].